Revna Biosciences Revenue

Research Services • Adenta, Greater Accra Region, Ghana • 21-50 Employees

Revna Biosciences revenue & valuation

Annual revenue	$1,967,765
Revenue per employee	$86,000
Estimated valuation?This valuation is estimated based on industry average for the Research Services industry and current estimated revenues	$6,300,000
Total funding	No funding

Key Contact at Revna Biosciences

Derrick Edem Akpalu

Ceo & Co-Founder

Company overview

Headquarters	Adenta, Greater Accra Region, Ghana
Phone number	+233599009989
Website	revnabio.com
NAICS	5417
SIC	283
Keywords	Healthcare, Research, Oncology, Medical Research, Laboratory, Clinical Trials, Ghana, West Africa, Genomics, Precision Medicine, Infectious Diseases, Disease Monitoring, Advanced Molecular Diagnostics, African Health
Founded	2017
Employees	21-50
Socials

Revna Biosciences Email Formats

Revna Biosciences uses 3 email formats. The most common is {first name}{last name} (e.g., johndoe@revnabio.com), used 78.3% of the time.

Format	Example	Percentage
{first name}{last name}	johndoe@revnabio.com	78.3%
{first initial}{last name}	jdoe@revnabio.com	13%
{f2}{last name}	{f2}doe@revnabio.com	8.7%

About Revna Biosciences

Advancing Precision Medicine for All. With an operational base in Accra, Ghana, and serving across West Africa, Revna Biosciences (RevnaBio) is at the forefront of precision medicine, driving innovations in molecular diagnostics, clinical research, and therapeutic discovery. Our mission is simple yet profound: to champion precision medicine for all. We are committed to uncovering the biological foundations of diseases affecting Africans, people of African descent, and the global population. RevnaBio offers a comprehensive suite of specialized biomedical services, including: ☑ Advanced molecular diagnostics ☑ Biobanking and biomarker discovery ☑ Clinical research and central lab services ☑ Disease monitoring and treatment selection ☑ Clinical trial management Through strategic partnerships with global biotech leaders—including QIAGEN, Diatech Pharmacogenetics, ABL Diagnostics, and Idil Biotech—we deliver cutting-edge biomedical solutions in the heart of West Africa. RevnaBio operates with full regulatory approvals and certifications, including: ✔ HeFRA tertiary laboratory permit ✔ Ghana FDA approval ✔ Dual ISO accreditations (ISO 15189:2022; ISO 20387:2018) by the American Association of Laboratory Accreditations (A2LA) ✔ Membership in ISBER (International Society of Biological and Environmental Repositories) Discover how Revna Biosciences is shaping the future of precision medicine. Contact us at +233-59-900-9977 or visit www.revnabio.com

Employees by Management Level

Total employees: 21-50

Seniority

Employees

Entry

Senior

Intern

Employees by Department

Revna Biosciences has 9 employees across 5 departments.

Departments

Number of employees

Funding Data

Explore Revna Biosciences's funding history, including investment rounds, total capital raised, and key backers.

Funding Date	Round	Amount	Link to Article
2024-04-27	9	N/A

Funding Insights

Number of funding rounds

Revna Biosciences Tech Stack

Discover the technologies and tools that power Revna Biosciences's digital infrastructure, from frameworks to analytics platforms.

Site Kit

Analytics

Swiper

JavaScript libraries

MailChimp for WordPress

Marketing automation

Google Maps

Maps

Microsoft 365

jQuery Migrate

JavaScript libraries

Blocksy

WordPress themes

Yoast SEO Premium

SEO

jQuery

JavaScript libraries

PHP

Programming languages

WordPress

Blogs

MailChimp

Frequently asked questions

Revna Biosciences is located in Adenta, Greater Accra Region, GH.

You can reach Revna Biosciences at +233599009989.

Revna Biosciences generates an estimated annual revenue of $1,967,765. This revenue figure reflects the company's market position and business performance in its industry.

Revna Biosciences has an estimated valuation of $6,300,000. This valuation is calculated based on industry-standard revenue multiples and reflects the company's growth potential and market positioning.

Revna Biosciences was founded in 2017, making it 9 years old. The company has established itself as a significant player in its industry over this time.

Revna Biosciences has approximately 21-50 employees. The company continues to grow its workforce to support its business operations and expansion.

Key Contact at Revna Biosciences

Derrick Edem Akpalu

Ceo & Co-Founder

4.8

40,000 users